Biotech International Limited, a New Delhi-based company that manufactures and markets biological products for agriculture and public health, reports strong financial performance for FY2025. According to multiple outlets, the company’s revenue for the financial year ended March 31, 2025 is in the range of INR 100–150 crore. The reports describe the company’s business focus as the production and marketing of biological products used in agriculture and public health. Both sources present the same headline figure range for revenue and reference the same reporting period. Beyond the revenue range and the company’s sector focus, the provided excerpts do not include additional financial details such as profit, year-on-year growth, segment-wise performance, or guidance. The coverage therefore centers on the stated revenue range for FY2025 and the company’s role in biological products for agriculture and public health.